Associations Between Inflammatory Mediators and Bone Outcomes in Postmenopausal Women: A Cross-Sectional Analysis of Baseline Data from the Prune Study

References

• Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 2009;9(8):1137–1141. doi:10.1002/jbmr.5650090802
   Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–795.
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733.
   PubMed Web of Science ®Google Scholar
• Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368–381.
   PubMed Web of Science ®Google Scholar
• Xiao PL, Cui AY, Hsu CJ, et al. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos Int. 2022;33(10):2137–2153.
   Web of Science ®Google Scholar
• Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017–2018. NCHS Data Brief. 2021;405:1–8.
   Google Scholar
• Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–475.
   PubMed Web of Science ®Google Scholar
• Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520–2526.
   PubMed Web of Science ®Google Scholar
• Singer A, Exuzides A, Spangler L, et al. Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc. 2015;90(1):53–62. doi:10.1016/j.mayocp.2014.09.011
   PubMed Web of Science ®Google Scholar
• Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11(7):556–561.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA, Odén A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38–42.
   PubMed Web of Science ®Google Scholar
• Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of Hip fractures in the United States. JAMA. 2009;302(14):1573–1579.
   PubMed Web of Science ®Google Scholar
• Lorentzon M, Johansson H, Harvey NC, et al. Osteoporosis and fractures in women: the burden of disease. Climacteric. 2022;25(1):4–10.
   PubMed Web of Science ®Google Scholar
• Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004.
   Google Scholar
• Blake J, Cosman FA, Lewiecki EM, et al. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973–997.
   Web of Science ®Google Scholar
• Hannan MT, Felson DT, Dawson-Hughes B, et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2010;15(4):710–720.
   Google Scholar
• Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576–581.
   PubMed Web of Science ®Google Scholar
• Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332(5):305–311.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J. Role of cytokines in postmenopausal bone loss. Curr Osteoporos Rep. 2003;1(2):53–58.
   Google Scholar
• Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996;11(8):1043–1051.
   PubMed Web of Science ®Google Scholar
• Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immun Ageing. 2005;2(1):14.
   Google Scholar
• Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65(12 Pt 2):S147–S151.
   Web of Science ®Google Scholar
• Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol a Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9.
   PubMed Web of Science ®Google Scholar
• Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586.
   PubMed Web of Science ®Google Scholar
• Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415–445.
   PubMedGoogle Scholar
• Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6(1):30.
   PubMedGoogle Scholar
• Sponholtz TR, Zhang X, Fontes JD, et al. Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women. Arthritis Care Res. 2014;66(8):1233–1240.
   Web of Science ®Google Scholar
• Ishii S, Cauley JA, Greendale GA, et al. C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women’s Health Across the Nation (SWAN). J Bone Miner Res. 2013;28(7):1688–1698.
   PubMed Web of Science ®Google Scholar
• Greendale GA, Jackson NJ, Han W, et al.. Increase in C-reactive protein predicts increase in rate of bone mineral density loss: the study of women’s health across the nation. JBMR Plus. 2021;5(4):e10480.
   Google Scholar
• Jackson RD, Donepudi S, Mysiw WJ. Epidemiology of fracture risk in the Women’s Health Initiative. Curr Osteoporos Rep. 2008;6(4):155–161.
   Google Scholar
• Bailey RL, Sahni S, Chocano-Bedoya P, et al. Best practices for conducting observational research to assess the relation between nutrition and bone: an International Working Group Summary. Adv Nutr. 2019;10(3):391–409.
   PubMed Web of Science ®Google Scholar
• Varela A, Jolette J. Bone Toolbox: biomarkers, Imaging Tools, Biomechanics, and Histomorphometry. Toxicol Pathol. 2018;46(5):511–529.
   Web of Science ®Google Scholar
• Lacroix AZ, Beck TJ, Cauley JA, et al. Hip structural geometry and incidence of Hip fracture in postmenopausal women: what does it add to conventional bone mineral density? Osteoporos Int. 2010;21(6):919–929.
   Web of Science ®Google Scholar
• Cheung AM, Frame H, Ho M, Mackinnon ES, Brown JP. Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice. Int J Womens Health. 2016;8:537–547.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Fujita H, Onozuka M, Kubo KY. Age-related changes in trabecular and cortical bone microstructure. Int J Endocrinol. 2013;213234:1–9.
   Google Scholar
• De Souza MJ, Strock NCA, Rogers CJ, et al. Rationale and study design of randomized controlled trial of dietary supplementation with prune (dried plums) on bone density, geometry, and estimated bone strength in postmenopausal women: the Prune study. Contemp Clin Trials Commun. 2022;28:100941.
   Web of Science ®Google Scholar
• De Souza MJ, Strock NCA, Williams NI, et al. Prunes preserve Hip bone mineral density in a 12-month randomized controlled trial in postmenopausal women: the Prune Study. Am J Clin Nutr. 2022;116(4):897–910.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES) 2017–2018 Procedure Manuals, National Center for Health Statistics. Rockville (MD): Department of Health and Human Services; 2017.
   Google Scholar
• Yang YJ, Martin BR, Boushey CJ. Development and evaluation of a brief calcium assessment tool for adolescents. J Am Diet Assoc. 2010;110(1):111–115.
   Google Scholar
• Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21:407–413.
   PubMed Web of Science ®Google Scholar
• McCloskey EV, Oden A, Harvey NC, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31(5):940–948.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Turner CH, Peacock M, et al. Geometric structure of the femoral neck measured using dual-energy x-ray absorptiometry. J Bone Miner Res. 1994;9(7):1053–1064.
   Web of Science ®Google Scholar
• Beck TJ, Ruff CB, Warden KE, Scott WW, Rao GU. Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol. 1990;25(1):6–18.
   PubMed Web of Science ®Google Scholar
• Morin S, Tsang JF, Leslie WD. Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int. 2009;20(3):363–370.
   Web of Science ®Google Scholar
• Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14(3 Pt 2):567–571.
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105–114.
   PubMed Web of Science ®Google Scholar
• Perry CD, Alekel DL, Ritland LM, et al. Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause. 2008;15(4 Pt 1):619–627.
   Web of Science ®Google Scholar
• Ilesanmi-Oyelere BL, Schollum L, Kuhn-Sherlock B, et al. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing. 2019;16(1):15.
   Google Scholar
• Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort. J Inflamm Res. 2021;14:567–573.
   PubMed Web of Science ®Google Scholar
• Schett G, Kiechl S, Weger S, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006;166(22):2495–2501.
   PubMedGoogle Scholar
• Pasco JA, Kotowicz MA, Henry MJ, et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006;296(11):1353–1355.
   PubMed Web of Science ®Google Scholar
• Cauley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: the health aging and Body Composition Study. J Bone Miner Res. 2007;22(7):1088–1095.
   PubMed Web of Science ®Google Scholar
• Cauley JA, Barbour KE, Harrison SL, et al. Inflammatory markers and the risk of hip and vertebral fractures in men: the Osteoporotic Fractures in Men (MrOS). J Bone Miner Res. 2016;31(12):2129–2138.
   PubMed Web of Science ®Google Scholar
• Barbour KE, Boudreau R, Danielson ME, et al. Inflammatory markers and the risk of Hip fracture: the Women’s Health Initiative. J Bone Miner Res. 2012;27(5):1167–1176.
   PubMed Web of Science ®Google Scholar
• Barbour KE, Lui LY, Ensrud KE, et al. Inflammatory markers and risk of Hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res. 2014;29(9):2057–2064.
   PubMed Web of Science ®Google Scholar
• Koh JM, Khang YH, Jung CH, et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005;16(10):1263–1271.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Choi K, et al. Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome. Nutr Res Pract. 2011;5(2):150–156.
   Web of Science ®Google Scholar
• De Martinis M, Sirufo MM, Nocelli C, Fontanella L, Ginaldi L. Hyperhomocysteinemia is associated with inflammation, bone resorption, vitamin B12 and folate deficiency and MTHFR C677T polymorphism in postmenopausal women with decreased bone mineral density. Int J Environ Res Public Health. 2020;17(12):4260.
   Web of Science ®Google Scholar
• Khinda R, Valecha S, Kumar N, et al. Prevalence and predictors of osteoporosis and osteopenia in postmenopausal women of Punjab, India. Int J Environ Res Public Health. 2022;19(5):2999.
   Web of Science ®Google Scholar
• Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 1994;79(3):707–711.
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Yakout S, Al-Shehri E, Al-Fawaz H, Aljohani N, Al-Saleh Y. Inflammatory and bone turnover markers in relation to PTH and vitamin D status among Saudi postmenopausal women with and without osteoporosis. Int J Clin Exp Med. 2014;7(9):2812–2819.
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Aziz I, Yakout S, et al. Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine. 2017;96(4):e5780.
   PubMed Web of Science ®Google Scholar
• Murad R, Shezad Z, Ahmed S, Ashraf M, Qadir M, Rehman R. Serum tumour necrosis factor alpha in osteopenic and osteoporotic postmenopausal females: a cross-sectional study in Pakistan. J Pak Med Assoc. 2018;68(3):428–431.
   Web of Science ®Google Scholar
• Gunn CA, Weber JL, Kruger MC. Diet, weight, cytokines and bone health in postmenopausal women. J Nutr Health Aging. 2014;18(5):479–486.
   Web of Science ®Google Scholar
• Cervellati C, Bonaccorsi G, Bergamini CM, et al. Association between circulatory levels of adipokines and bone mineral density in postmenopausal women. Menopause. 2016;23(9):984–992.
   PubMed Web of Science ®Google Scholar
• Azizieh FY, Shehab D, Al Jarallah K, Mojiminiyi O, Gupta R, Raghupathy R. Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD. J Inflamm Res. 2019;12:99–108.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang X, Sun K, et al. The potential role of serum IGF-1 and leptin as biomarkers: towards screening for and diagnosing postmenopausal osteoporosis. J Inflamm Res. 2022;15:533–543.
   PubMed Web of Science ®Google Scholar
• Tworoger SS, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1578–1581.
   PubMed Web of Science ®Google Scholar
• Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014;545493:1–24.
   Google Scholar
• Azizieh F, Raghupathy R, Shehab D, Al-Jarallah K, Gupta R. Cytokine profiles in osteoporosis suggest a proresorptive bias. Menopause. 2017;24(9):1057–1064.
   PubMed Web of Science ®Google Scholar
• Azizieh FY, Al Jarallah K, Shehab D, Gupta R, Dingle K, Raghupathy R. Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis. Rheumatol Int. 2017;37(10):1727–1734.
   PubMed Web of Science ®Google Scholar
• Dingle K, Azizieh F. Multivariate comparison of cytokine profiles for normal- and low-bone-density subjects. Diagnostics. 2019;9(4):134.
   Web of Science ®Google Scholar
• Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Föger-Samwald U, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology. 2016;62(2):128–137.
   PubMed Web of Science ®Google Scholar
• Hlaing TT, Compston JE. Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem. 2014;51(Pt 2):189–202.
   PubMed Web of Science ®Google Scholar
• Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K. Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc. 2005;97(3):329–333.
   PubMed Web of Science ®Google Scholar
• Bhupathiraju SN, Alekel DL, Stewart JW, et al. Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women. J Clin Densitom. 2007;10(4):395–403.
   Web of Science ®Google Scholar
• Nabipour I, Larijani B, Vahdat K, et al. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Menopause. 2009;16(5):950–955.
   Web of Science ®Google Scholar
• Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP. Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol. 1997;16(2):162–165.
   Web of Science ®Google Scholar
• Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29(3):518–530.
   PubMed Web of Science ®Google Scholar
• Khosla S, Pacifici R. Estrogen deficiency, postmenopausal osteoporosis, and age-related bone loss. In: Marcus R, Feldman D, David WD, editors. Osteoporosis. 4th ed. San Diego: Academic Press; 2013:1113–1136.
   Google Scholar
• Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999;100(7):713–716.
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. JAMA. 2002;288(8):980–987.
   PubMed Web of Science ®Google Scholar
• Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93(5):1952–1958.
   PubMed Web of Science ®Google Scholar
• Gertz ER, Silverman NE, Wise KS, et al. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010;13(3):277–282.
   Web of Science ®Google Scholar
• Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001;86(5):2032–2042.
   PubMed Web of Science ®Google Scholar
• Zupan J, Komadina R, Marc J. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. J Biomed Sci. 2012;19(1):28.
   PubMedGoogle Scholar
• Seeman E. Age- and menopause-related bone loss compromise cortical and trabecular microstructure. J Gerontol a Biol Sci Med Sci. 2013;68(10):1218–1225.
   PubMed Web of Science ®Google Scholar
• Bjørnerem Å, Wang X, Bui M, et al. Menopause-related appendicular bone loss is mainly cortical and results in increased cortical porosity. J Bone Miner Res. 2018;33(4):598–605.
   PubMed Web of Science ®Google Scholar
• Chapurlat R, Bui M, Sornay‐Rendu E, et al. Deterioration of cortical and trabecular microstructure identifies women with osteopenia or normal bone mineral density at imminent and long‐term risk for fragility fracture: a prospective study. J Bone Miner Res. 2020;35(5):833–844.
   Web of Science ®Google Scholar
• Lauretani F, Bandinelli S, Russo CR, et al. Correlates of bone quality in older persons. Bone. 2006;39(4):915–921.
   PubMed Web of Science ®Google Scholar
• Zhu TY, Griffith JF, Qin L, et al. Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case-control study with HR-pQCT. J Bone Miner Res. 2014;29(9):2118–2129.
   PubMed Web of Science ®Google Scholar
• Hou JHC, He W, Yang M, Luo X, Li C. Obesity and bone health: a complex link. Front Cell Dev Biol. 2020;8:600181.
   PubMed Web of Science ®Google Scholar
• Fassio A, Idolazzi L, Rossini M, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293–302.
   PubMed Web of Science ®Google Scholar
• Demirkol ME, Bilgin S, Kahveci G, et al. C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study. Cir Cir. 2022;90(5):596–601.
   PubMed Web of Science ®Google Scholar
• Demirkol ME, Aktas G, Bilgin S, et al. C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study. Rev Assoc Med Bras. 2022;68(6):838–841.
   Web of Science ®Google Scholar
• Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832.
   PubMed Web of Science ®Google Scholar
• Bilgin S, Kurtkulagi O, Atak Tel BM, et al. Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study. Prim Care Diabetes. 2021;15(6):1071–1074.
   PubMed Web of Science ®Google Scholar
• Demirkol ME, Aktas G. C‐reactive protein to LymphocytE count ratio could be a reliable mArkeR of thyroiditis; the CLEAR‐T study. Precis Med Sci. 2022;11:31–34.
   Google Scholar
• Weitzmann MN. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006;116(5):1186–1194. doi:10.1172/JCI28550
   PubMed Web of Science ®Google Scholar
• Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol. 2021;12:687551.
   Web of Science ®Google Scholar
• Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med. 2013;23(1):43–63.
   Web of Science ®Google Scholar